Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer.
暂无分享,去创建一个
A. Goldhirsch | B. Thürlimann | D. Crivellari | G. Martinelli | C. Sessa | M. Borner | A. Buonadonna | O. Pagani | D. Hess | M. Zimatore | J. Bauer | A. Riva | R. Graffeo | G. Zampino